1WHO.Task force on post ovulatory methods for fertility regulation: termination of early human pregnancy with RU 486 ( mifeprestone ) and the prostaglandin analogue Sulprostone: a multicenter randomized comparison between two treatment regimens. Human Reproduction . 1989
2WHO Task Force on post-ovulatory methods for Fertility Regulation.Pregnancy termination with minfepristone and gemeprpst:a multi-center comparison between repeated doses and a single of mifepristone. Fertility and Sterility . 1991
3He Chang-hai.et al.Clinical pharmacodynamics of mifepristone (RU486) in the Chinese pregnant women. Second International Conference on Reproductive Endocrinology . 1992
4WHO.Differences in Coagulation and Haemostatic Parameters in Normal Women of Childbearing Age from Different Ethnic Groups and Geographical Locations. Thrombosis and Haemostasis . 1986
5He Chang-hai.Study on safety and efficacy of mifepristone plus misoprostol for ternination of early pregnlancy. Reproduction and Contraception . 1992
6He Chang-hai Shi Yong-en Ye Zhi-hou Zhang Guo-qing Jiang Nai-xiong P. F. A. Van Look and K. Fotherby 4.Pharmacokinetic study of orally administered RU 486 in non-pregnant women. Contraception . 1989
7P. A. Kalra,D. Litherland,D. F. Sallomi,H. O. D. Critchley,G. F. Falconer and A. M. Holmes.CARDIAC STANDSTILL INDUCED BY PROSTAGLANDIN PESSARIES. The Lancet . 1989
8Aubeny,E,Baulieu,EE.Contragestation with RU 486 and orally active prostaglandin. Comptes Rendus de l Académie des Sciences Series IV Physics Astrophysics . 1991
9Norman JE,Thong KJ,Baird DT.Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone. The Lancet . 1991
10A death associated with mifepristone/ sulprostone. The Lancet . 1991
